Sue Wallace is the Chief Executive Officer of Voximetry Incorporated, a Healthtech start-up with software designed to change the Standard of Care for late-stage prostate cancer patients by creating personalized treatment plans tailored for the individual. Educated in nuclear and radiopharmaceutical chemistry, Dr. Wallace has extensive experience in medical device R&D, commercialization, and global business general management.
She has proven success within Fortune 500 companies, startups, early-stage ventures and late life-cycle rescues. She has held global, executive leadership positions with GE Healthcare, Philips Healthcare, Cardinal Health, Abiomed, and Accuray.
Born in Racine, Wisconsin, Dr. Wallace is a GE trained Six Sigma Master Black Belt. She holds a B.S. degree from the University of Wisconsin, and a Master of Science in Nuclear Chemistry & Doctorate in Radiopharmaceutical Chemistry from Washington University in St. Louis.
She is best known as a highly intelligent, insightful visionary. She has been a frequent speaker on innovation and creating productive eco-systems and was a keynote speaker on “Embracing Madness” at the 2014 Bioforward conference.